Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on Routine Testing for Latent Tuberculosis Infection Prior To and During Treatment of Psoriasis Patients with IL-17 or IL-23 Inhibitors

Journal:

Journal of the American Academy of Dermatology

Published:

2025-11-21

DOI:

10.1016/j.jaad.2025.11.033

Affiliations:

17

Authors:

16

Go to article

Institutions	Authors	Share
University of Pennsylvania (Penn), United States of America (USA)	2.000000	0.13
National Psoriasis Foundation, United States of America (USA)	2.000000	0.13
International Psoriasis Council (IPC), United States of America (USA)	1.500000	0.09
Oregon Health and Science University (OHSU), United States of America (USA)	1.000000	0.06
Yale University, United States of America (USA)	1.000000	0.06
Blauvelt Consulting, LLC, United States of America (USA)	1.000000	0.06
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	1.000000	0.06
UCLA Health, United States of America (USA)	1.000000	0.06
University of Porto (UP), Portugal	1.000000	0.06
University of São Paulo (USP), Brazil	1.000000	0.06
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)	1.000000	0.06
Hospital Sultanah Aminah (HSA), Malaysia	0.500000	0.03
Monash University Malaysia Campus, Malaysia	0.500000	0.03
Hospital de la Santa Creu i Sant Pau, Spain	0.500000	0.03
Autonomous University of Barcelona (UAB), Spain	0.500000	0.03
Radboud University Medical Centre (Radboudumc), RU, Netherlands	0.500000	0.03

Interested in Clinical Sciences?